Trials / Withdrawn
WithdrawnNCT01495715
Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Santhera Pharmaceuticals · Industry
- Sex
- All
- Age
- 10 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to determine whether administration of idebenone can shorten the time to improvement of visual acuity in patients with chronic vision loss due to LHON.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Idebenone | |
| DRUG | Placebo |
Timeline
- First posted
- 2011-12-20
- Last updated
- 2014-08-22
Source: ClinicalTrials.gov record NCT01495715. Inclusion in this directory is not an endorsement.